Skip to content

Microbiome of Donor Iron Deficient Study

Microbiome of Donor Iron Deficient Study (DIDS)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02990988
Enrollment
70
Registered
2016-12-13
Start date
2017-01-31
Completion date
2022-06-03
Last updated
2022-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron Deficiency

Keywords

Blood donation, Iron repletion, Transfusion

Brief summary

The goal of this pilot study is to test whether the microbiome is affected by intravenous iron repletion.

Detailed description

The colonic microbiome, the community of bacteria living in our gut, is essential in human health and disease. Iron is an essential nutrient for both bacteria and humans. In the United States, of the donors who provided the \ 15 million units of red blood cells that were collected for transfusion, 69% were repeat donors. Although iron deficiency is surprisingly prevalent in first-time donors, its prevalence is even higher in these particularly altruistic frequent donors, (i.e., up to 49% and 66% of male and female repeat donors, respectively), manifested as iron depletion or iron-deficient erythropoiesis. Iron deficiency from blood donation is associated with fatigue, restless leg syndrome, decreased physical endurance and work capacity, and impaired concentration, attention, and other neurocognitive functions; however, these conclusions are not based on definitive studies and have not yet changed blood donation policy. The goal is to conduct a prospective, double-blind, randomized controlled trial, recruiting 60 healthy regular donors who meet donation standards, while exhibiting iron-deficient erythropoiesis by laboratory test criteria. In this ancillary study, we will determine what effect donor iron deficiency and IV iron repletion have on the gut microbiome.

Interventions

None listed

Sponsors

Columbia University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Current participant of the associated randomized controlled trial conducted at Columbia University Medical Center (therefore invited to participate in this optional ancillary study).

Exclusion criteria

* Not a current participant of the associated randomized controlled trial conducted at Columbia University Medical Center.

Design outcomes

Primary

MeasureTime frameDescription
Change in overall diversity of fecal floraBaseline, 5-days, 4-weeks, 5 monthsStool samples will be collected and processed.
Change in fecal indolesBaseline, 5-days, 4-weeks, 5 monthsIndole concentrations measured in fecal samples
Change in fecal ironBaseline, 5-days, 4-weeks, 5 monthsIron concentrations measured in fecal samples

Secondary

MeasureTime frameDescription
Mean Bray-Curtis indicesBaseline, 5-days, 4-weeks, 5 monthsCalculation of Bray-Curtis index will determine the relative abundance of specific taxa (e.g., Firmicutes, Bacteroidetes, Proteobacteria) for each subject. Means (of the differences in %) and standard deviations will be calculated for all comparisons, and a multivariable generalized estimating equations (GEE) model will be used to test for significance.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026